Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users (iTAB)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
David J. Moore, Ph.D., University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01317277
First received: March 16, 2011
Last updated: June 24, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)